EMEA-000709-PIP01-09-M05

Key facts

Invented name
Inovelon
Active substance
Rufinamide
Therapeutic area
Neurology
Decision number
P/0116/2016
PIP number
EMEA-000709-PIP01-09-M05
Pharmaceutical form(s)
  • Tablet
  • Oral suspension
Condition(s) / indication(s)
Treatment of Lennox-Gastaut syndrome
Route(s) of administration
Oral use
Contact for public enquiries
Eisai Limited
United Kingdom
Tel. +44 (0)8456 761400
E-mail: eumedinfo@eisai.net
Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating